Nicole Yurgin, PhD is a seasoned biopharma leader with 20+ years of experience across market access functions. She has held senior evidence and access roles at Lilly, Amgen, and Novartis, most recently as Global Head of Value and Access at Novartis, where she led teams in market access, pricing, HEOR, and health policy. Nicole brings deep U.S. expertise—gained through in-country roles and direct payer engagement—alongside extensive experience navigating European healthcare systems. Through Yurgin Advisory, she partners with life sciences companies and investors to translate evidence and strategy into real-world access, ensuring innovation drives meaningful change for patients.